In HBV-related hepatocellular carcinoma, the expression of the lactylation eraser SIRT3 was substantially lower in tumor tissues and was negatively correlated with the tumor stage (Gao et al., 2019). Here, SIRT3 is linked to hepatocellular carcinoma.